8,328 Shares in iShares Biotechnology ETF $IBB Bought by Northstar Advisory Group LLC

Northstar Advisory Group LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,328 shares of the financial services provider’s stock, valued at approximately $1,406,000.

A number of other institutional investors also recently bought and sold shares of the business. Columbus Macro LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at $3,177,000. Ocean Park Asset Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $7,396,000. Stegent Equity Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $1,493,000. Spire Wealth Management increased its position in iShares Biotechnology ETF by 44.7% during the fourth quarter. Spire Wealth Management now owns 2,750 shares of the financial services provider’s stock worth $464,000 after buying an additional 850 shares during the period. Finally, Chesley Taft & Associates LLC lifted its stake in iShares Biotechnology ETF by 3.9% in the fourth quarter. Chesley Taft & Associates LLC now owns 26,407 shares of the financial services provider’s stock valued at $4,457,000 after buying an additional 990 shares during the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $161.86 on Tuesday. The company’s 50 day simple moving average is $171.00 and its 200-day simple moving average is $164.50. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.